Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8775860 | Urology | 2018 | 18 Pages |
Abstract
We present a review comparing the use of tadalafil daily vs on-demand for erectile dysfunction. We examined randomized controlled trials and observational studies that examined the use of tadalafil for at least 8 weeks of follow-up with the primary outcome of International Index for Erectile Dysfunction-Erectile Function domain. Eight studies that examined the desired dosing regimens were identified. Of these, 6 studies included the primary end point of 12 weeks. Those patients taking tadalafil daily for 12 weeks scored on average 1.82 points higher in International Index for Erectile Dysfunction-Erectile Function domain scores, although the difference may not be clinically significant (Fig. 1).
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Utsav K. Bansal, Cameron Jones, Thomas W. Fuller, Charles Wessel, Stephen V. Jackman,